Online Extras

An Applied Clinical Trials Editorial Advisory Member gives his opinion on where the differences lie between EDC and ePRO systems.

A rundown for sponsors of the right questions to ask and facts to check before selecting a CRO.

FDA has updated its guidance documents for 1572s.

How cultural and training differences affect molecular-based clinical research in China.

A brief look back at the recent 18th Annual Partnerships with CROs.

An interview with Dr. Albert Edwards offers his take on how pilot testing can ease the implementation of eCTD.

A look back at DIA's 2009 EuroMeeting.

Find out from clinical trial professionals why they utilize bid grids to select an outsourcing partner.

Finding a strategic approach to writing clinical study reports.

Hear from Quintiles' senior director of global regulatory affairs and medical writing on moving from a paper to electronic submission.

A case study of the Duke Clinical Research Institute's implementation of Oracle's CTMS shows flexibility is vital.

Janel Firestein, our roundtable moderator, offers her take on the expert discussion and the major challenge she sees to eCTD implementation.

Recent legislative and regulatory changes increase the country's appeal as a destination for research.

Notes from IIR's Clinical Trials Congress 2009 held this past February in Philadelphia.

A program-level view allows users to get to the bottom of mid-study, and potentially, trial altering requests in a more time conscious manner.

How regulatory agencies on both sides of the Atlantic are working toward transatlantic harmonization.

From London, Applied Clinical Trial's Editor-in-Chief Lisa Henderson provides an update on CBI's Inaugural Clinical Trial Registries and Results Databases conference.

Praxis' director of marketing, Chris Layfield, offers insight into patient recruitment and developing a strategic recruitment plan when conducting medical device trials.

MassBio president Dan McDonald discusses Massachusetts' bio industry and its ability to continually evolve despite the economic downturn.

Regional centralized labs are emerging to support global clinical trials.